| 沸点 | 157-158 °C/16 mmHg |
| 熔点 | 43-46 °C |
| 敏感性 | 对湿度敏感 |
| 存贮条件 | 充氩保存 |
| 应用 | 3,5-Dimethoxybenzoyl chloride was used to study the mechanism and kinetics of solvolysis of 3,4- and 3,5-dimethoxybenzoyl chlorides in various binary solvents. |
| 产品介绍 | 3,5-Dimethoxybenzoyl chloride undergoes addition reaction with 4,4-dimethyl-2-pentyne in presence of AlCl3 via 1,2- methyl shift. |
| 别名 | ; |
3,5-二甲氧基苯甲酰氯
3,5-Dimethoxybenzoyl Chloride （订货以英文为准）
编号：D156028
CAS号：17213-57-9
分子式：C9H9CLO3
分子量：200.62
| 产品名称 | 3,5-Dimethoxybenzoyl Chloride |
| 中文名称 | 3,5-二甲氧基苯甲酰氯 |
| CAS号 | 17213-57-9 |
| MDL编码 | MFCD00000676 |
| 分子式（M.F.） | C9H9CLO3 |
| 分子量（M.W.） | 200.62 |
| 储存条件 | 充氩 |
| Reaxys-RN | 9508007 |
技术规格
| Background: | ZFYVE19 (zinc finger, FYVE domain containing 19), also known as MPFYVE (MLL partner containing FYVE domain), is a 471 amino acid protein that contains one FYVE-type zinc finger. Expressed in heart, brain, kidney, skeletal muscle and liver, ZFYVE19 may participate in transcriptional regulation events within the cell. Defects in the gene encoding ZFYVE19 are associated with acute myeloblastic leukemia (AML), a rapidly progressing cancer of the myeloid line of white blood cells that is characterized by fever, anemia, bone pain, shortness of breath and frequent infections. Three isoforms of ZFYVE19 exist due to alternative splicing events. |
| Applications: | ELISA, WB, IHC |
| Name of antibody: | ZFYVE19 |
| Immunogen: | Synthetic peptide of human ZFYVE19 |
| Full name: | zinc finger, FYVE domain containing 19 |
| Synonyms： | MPFYVE |
| SwissProt: | Q96K21 |
| ELISA Recommended dilution: | 2000-5000 |
| IHC positive control: | Human tonsil and Human liver cancer |
| IHC Recommend dilution: | 50-200 |
| WB Predicted band size: | 52 kDa |
| WB Positive control: | Hela and A431 cells |
| WB Recommended dilution: | 500-2000 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 420.00
01484972-4L
¥ 1520.00
BWY0821011-1mL
¥ 259.00
sh24567-1个
¥ 5212.00
2106-0016-1箱
¥ 3406.00
2106-0002 -1箱
¥ 3289.00
2106-0001-1箱
¥ 510.00
P9157-50T-PKG-5T
党沛 
